Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $352.00 | $19.12 | 1,741.24% | 7,040.00x | 103.91x | 7.80x | 9.44x | 6.80x | $529.27M | 1.36% | $4.13B | 37.48 | $36.86B | 115.90 | ||
| NVO | NOVO NORDISK A S | $47.19 | $147.93 | -68.10% | 12.93x | 2.07x | 4.31x | 6.86x | 0.13x | $9.33B | 4.43% | $30.70B | 6.88 | $227.24B | 9.42 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $351.96 | $36.44 | 865.96% | 1,135.35x | 52.54x | 14.41x | 198.80x | 3.69x | $221.36M | 0.48% | $233.89M | 1.78 | $48.22B | 317.41 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $43.52 | $17.56 | 147.85% | 88.82x | 27.28x | 5.44x | 6.16x | 1.07x | $101.73M | 3.13% | $535.38M | 7.17 | $3.13B | 58.49 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.94 | $16.30 | -45.14% | 18.63x | 15.79x | 5.93x | 3.78x | 0.24x | -$23.64M | -4.73% | $133.17M | 2.38 | $511.58M | 7.61 | ||
| CORT | CORCEPT THERAPEUTICS INC | $40.13 | $41.31 | -2.87% | 40.13x | 64.85x | 5.61x | 6.68x | 0.41x | $162.57M | 3.91% | $631.90M | 6.10 | $4.10B | 62.18 | ||
| VCEL | VERICEL CORP | $36.88 | $9.49 | 288.81% | 141.85x | 65.07x | 7.20x | 5.80x | 1.68x | $20.38M | 1.10% | $321.86M | 6.38 | $1.86B | 63.55 | ||
| ARGX | ARGENX SE | $850.87 | $367.09 | 131.79% | 34.00x | 28.38x | 27,447.42x | 7.24x | 1.38x | $467.72M | 0.90% | $7.17B | 117.50 | $49.53B | 61.05 | ||
| KRYS | KRYSTAL BIOTECH INC | $269.13 | $118.00 | 128.07% | 39.00x | 32.32x | 20.88x | 6.86x | 1.24x | $166.02M | 2.13% | $1.14B | 39.30 | $7.42B | 38.39 | ||
| TECH | BIO-TECHNE CORP | $68.67 | $16.31 | 320.98% | 132.06x | 34.00x | 8.80x | 5.34x | 1.87x | $223.02M | 2.08% | $2.01B | 12.90 | $10.92B | 48.23 | ||
| ADMA | ADMA BIOLOGICS INC | $16.49 | $12.63 | 30.52% | 18.74x | 18.06x | 8.05x | 9.10x | 0.79x | $40.73M | 1.04% | $431.19M | 1.81 | $3.94B | 22.87 | ||
| GMAB | GENMAB A | $31.90 | $126.82 | -74.85% | 13.62x | 1.89x | 5.75x | 3.56x | 0.10x | $1.19B | 5.83% | $5.75B | 8.96 | $18.86B | 9.43 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.08 | $18.96 | -73.20% | 3.19x | -94.25x | 725.71x | 1.61x | 0.19x | -$82.36M | -29.88% | $171.23M | 3.16 | $216.18M | 2.41 | ||
| MNKD | MANNKIND CORP | $5.78 | $2.91 | 98.79% | 57.80x | 66.21x | 5.65x | -39.84x | 0.90x | $43.39M | 2.44% | -$44.55M | -0.15 | $2.01B | 27.43 | ||
| VCYT | VERACYTE INC | $36.10 | $12.34 | 192.66% | 92.56x | 31.95x | 5.74x | 2.27x | 1.30x | $98.21M | 3.46% | $1.26B | 15.98 | $2.58B | 45.21 | ||
| RPRX | ROYALTY PHARMA PLC | $43.68 | $46.54 | -6.15% | 24.82x | 8.42x | 8.03x | 2.62x | 0.44x | $2.11B | 11.19% | $9.62B | 22.28 | $33.22B | 31.81 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.58 | $9.77 | 49.27% | 25.14x | 15.29x | 7.23x | 5.26x | 0.82x | $119.87M | 6.23% | $365.77M | 2.78 | $1.93B | 18.62 | ||
| XOMA | XOMA ROYALTY CORP | $26.91 | $15.72 | 71.20% | 33.22x | 85.59x | 6.93x | 3.79x | 0.88x | -$12.41M | -3.80% | $87.94M | 7.25 | $374.67M | 14.01 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $5.54 | $4.29 | 29.19% | 20.52x | 18.41x | 3.54x | 6.26x | 0.73x | $21.15M | 4.78% | $70.68M | 0.89 | $380.89M | 16.79 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $198.33 | $71.70 | 176.62% | 85.86x | 23.44x | 15.46x | 4.11x | 1.23x | $30.76M | 0.79% | $950.17M | 48.53 | $4.22B | 40.92 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $23.15 | $6.10 | 279.36% | 66.14x | -20.14x | 2.88x | 7.30x | 2.05x | $78.64M | 2.69% | $401.17M | 3.17 | $2.92B | 31.31 | ||
| EXEL | EXELIXIS INC | $42.65 | $36.07 | 18.24% | 17.34x | 13.12x | 5.00x | 5.29x | 0.70x | $779.77M | 6.81% | $2.16B | 8.05 | $11.24B | 12.11 | ||
| HALO | HALOZYME THERAPEUTICS INC | $77.93 | $80.56 | -3.26% | 15.94x | 9.35x | 7.35x | 18.19x | 0.54x | $602.40M | 6.59% | $503.92M | 4.30 | $10.26B | 12.13 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.90 | $3.54 | -18.19% | 41.43x | 16.40x | 3.72x | 4.41x | 0.34x | -$11.69M | -5.07% | $52.91M | 0.67 | $227.75M | 25.67 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $25.06 | $23.31 | 7.51% | 14.00x | 13.80x | 5.31x | 3.35x | 0.70x | $234.54M | 7.63% | $920.25M | 7.51 | $2.39B | 7.39 | ||
| CRMD | CORMEDIX INC | $7.84 | $14.42 | -45.63% | 3.45x | 4.82x | 2.78x | 1.65x | 1.93x | $74.42M | 12.50% | $374.13M | 4.93 | $718.13M | 6.40 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $470.52 | $189.12 | 148.79% | 32.88x | 23.08x | 10.26x | 6.89x | 1.59x | $3.34B | 2.77% | $17.32B | 67.76 | $116.27B | 24.94 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.62 | $50.89 | 13.22% | 21.18x | 13.00x | 3.58x | 1.83x | 0.59x | $832.13M | 7.52% | $6.06B | 31.54 | $10.42B | 13.48 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.32 | $62.82 | -40.59% | 11.55x | 8.64x | 2.60x | 2.57x | 0.31x | $296.89M | 13.82% | $835.12M | 14.51 | $1.67B | 6.20 | ||
| UTHR | UNITED THERAPEUTICS CORP | $482.59 | $253.06 | 90.71% | 16.94x | 16.38x | 6.76x | 3.15x | 1.94x | $1.12B | 5.31% | $6.59B | 150.46 | $19.44B | 10.96 | ||
| INVA | INNOVIVA INC | $21.48 | $19.24 | 11.64% | 11.37x | 9.83x | 3.82x | 1.59x | 0.92x | $196.54M | 13.25% | $1.01B | 14.63 | $1.39B | 6.46 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $775.06 | $442.60 | 75.11% | 18.00x | 16.68x | 5.65x | 2.62x | 1.43x | $4.08B | 5.03% | $31.26B | 298.82 | $81.53B | 14.01 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $24.23 | $12.08 | 100.55% | 15.43x | 31.67x | 3.91x | 4.47x | 2.82x | $197.81M | 4.84% | $917.27M | 5.43 | $3.87B | 13.47 | ||
| MDXG | MIMEDX GROUP INC | $5.11 | $2.66 | 91.98% | 18.25x | 45.54x | 1.92x | 3.17x | 1.74x | $66.82M | 8.83% | $238.95M | 1.61 | $632.93M | 9.14 | ||
| INCY | INCYTE CORP | $102.60 | $75.85 | 35.26% | 16.99x | 12.81x | 4.17x | 4.33x | 0.90x | $1.20B | 5.96% | $4.65B | 23.77 | $17.72B | 10.53 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.